A significant advancement in drug development has emerged from the University of Gothenburg, where researchers have created stable boron-fluorine compounds. This breakthrough allows for enhanced efficacy...
Chris Gibson, the co-founder and Chief Executive Officer of Recursion, is stepping down from his role after 12 years at the helm. This transition will take...
